Inflammation

, Volume 10, Issue 4, pp 363–369 | Cite as

Response of human neutrophils to formyl-peptide modified at the terminal amino and carboxyl groups

  • Susanna Spisani
  • Teresa Cavalletti
  • Riccardo Gavioli
  • Angelo Scatturin
  • Gianni Vertuani
  • Serena Traniello
Original Articles

Abstract

Two analogs of chemotactic peptideN-formyl-l-methionyl-l-leucyl-l-phenylalanine were examined for their capacity to activate several functions of human neutrophils. The C-terminus methyl ester derivative of the chemotactic peptide was found to possess strong biological activity and was able to induce levels of chemotaxis, enzyme secretion, and Superoxide generation comparable to those observed with the same concentrations ofN-formyl-l-methionyl-l-leucyl-l-phenylalanine. The analog containing atert-butyloxycarbonyl group at the N-terminus, as well as the C-terrninal methyl ester, was completely devoid of activity towards neutrophils. From these results, it appears that the free carboxyl group is not necessary for biological function. In contrast, the substituent at the N-terminus may play a critical role in the induction of the cellular response.

Keywords

Peptide Methyl Ester Internal Medicine Superoxide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Showell, H. J., R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswanikumar, B. A. Corcoran, andE. L. Becker. 1976. The structure activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils.J. Exp. Med. 143:1154–1169.Google Scholar
  2. 2.
    Becker, E. L., M. Sigman, andJ. M. Oliver. 1979. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.Am. J. Pathol. 95:81–89.Google Scholar
  3. 3.
    Wilkinson, P. C. 1979. Synthetic peptide chemotactic factors for neutrophils: The range of active peptide, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzyme and bacterial toxins.Immunology 36:579–588.Google Scholar
  4. 4.
    Ho, P. P., A. L. Young, andG. L. Southard. 1978. Chemotactic response of human blood monocytes and inhibition of gold compounds.Arthritis Rheum. 21:133–136.Google Scholar
  5. 5.
    Freer, R. T., A. R. Day, J. A. Radding, E. Schiffmann, S. Nikumar, H. J. Showell, andE. L. Becker. 1980. Further studies on the structural requirements for synthetic peptide.Biochemistry 19:2404–2410.Google Scholar
  6. 6.
    Freer, R. J., A. R. Day, N. Muthukumaraswamy, D. Pinon, A. Wu, H. J. Showell, andE. L. Becker. 1982. Formyl peptide chemoattractants: A model of the receptor on rabbit neutrophils.Biochemistry 21:257–263.Google Scholar
  7. 7.
    Spisani, S., C. Marangoni, andS. Traniello. 1984. Effect of antiinflammatory drugs on leukocyte Superoxide production by soluble and paniculate stimuli.Biochem. Int. 9:1–8.Google Scholar
  8. 8.
    Spisani, S., E. Vincenzi, S. Traniello, G. P. Pollini, andA. Barco. 1982. Synthetic prostaglandin analog: In vitro studies on human neutrophils.Immunopharmacology 4:323–330.Google Scholar
  9. 9.
    Tognolo, C., G. M. Bonora, H. Showell, R. J. Freer, andE. L. Becker. 1984. Structural requirements for formyl homooligopeptide chemoattractants.Biochemistry 23:698–704.Google Scholar
  10. 10.
    Zigmond, S. H., andJ. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis: New methods for evaluation and demonstration of a cell derived chemotactic factor.J. Exp. Med. 137:387–410.Google Scholar
  11. 11.
    Spisani, S., C. Marangoni, L. Dovigo, andS. Traniello. 1984. Effect of antiinflammatory agents on neutrophil Superoxide production in rheumatoid arthritis.Inflammation 8:45–52.Google Scholar
  12. 12.
    Schneider, R. C., R. Gennaro, G. De Nicola, andD. Romeo. 1978. Secretion of granule enzyme from alveolar macrophages.Exp. Cell. Res. 112:249–256.Google Scholar
  13. 13.
    Showell, H. J., D. Williams, E. L. Becker, P. H. Naccache, andR. Sha'afi. 1979. Desensitization and deactivation of the secretory responsiveness of rabbit neutrophils induced by the chemotactic peptide, formyl-methionyl-leucyl-phenylalanine.J. Reticul. Soc. 25:139–150.Google Scholar
  14. 14.
    Spisani, S., andS. Traniello. 1979. Effect of mediators of inflammation on human neutrophil motility.In Advances in Inflammation Research, Vol. 1. G. Weissman, B. Samuelsson, and R. Paoletti, Editors. Raven Press, New York, 237–245.Google Scholar
  15. 15.
    Van Epps, D. E., andR. Williams. 1976. Suppression of leukocyte chemotaxis by human IgA myeloma components.J. Exp. Med. 144:1227–1242.Google Scholar
  16. 16.
    Keller, H. U., S. Barandun, P. Kistler, andJ. Ploem. 1979. Locomotion and adhesion of neutrophil granulocytes: Effects of albumin, fibrinogen, and globulins studied by reflexion contrast microscopy.Exp. Cell. Res. 122:351–362.Google Scholar
  17. 17.
    Aswanikumar, S., E. Schiffman, B. A. Corcoran, C. B. Pert, J. L. Morell, andE. Gross. 1978. Antibiotic and peptides with agonist and antagonist chemotactic activity.Biochem. Biophys. Res. Commun. 80:464–471.Google Scholar
  18. 18.
    Marasco, W. A., H. J. Showell, andE. L. Becker. 1981. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil.Biochem. Biophys. Res. Commun. 99:1065–1072.Google Scholar

Copyright information

© Plenum Publishing Corporation 1986

Authors and Affiliations

  • Susanna Spisani
    • 1
  • Teresa Cavalletti
    • 1
  • Riccardo Gavioli
    • 1
  • Angelo Scatturin
    • 2
  • Gianni Vertuani
    • 2
  • Serena Traniello
    • 1
  1. 1.Istituto di Chimica BiologicaUniversità di FerraraFerraraItaly
  2. 2.Istituto di Chimica FarmaceuticaUniversità di FerraraFerraraItaly

Personalised recommendations